Genomic surveillance of respiratory syncytial virus during 2023/2024 nirsevimab prophylaxis, Eastern Spain, early results

Clinical Microbiology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles